Thyrocare Technologies Share PriceThyrocare Technologies

₹568.3
14.5 (2.62%)
As on 30 September, 2023 | 18:51 BSE: 539871 NSE: THYROCAREISIN: INE594H01019

Thyrocare Technologies Performance

Day Range

  • Low 554.95
  • High 574.95
568.3

52 Week Range

  • Low 415.4
  • High 768.25
568.3
  • Open Price556.6
  • Previous Close553.8
  • Volume70186

Start SIP in Thyrocare Technologies

Start SIP

Thyrocare Technologies Share Price

  • Over 1 Month 2.84%
  • Over 3 Month 8.9%
  • Over 6 Month 34.91%
  • Over 1 Year -19.09%

Thyrocare Technologies Key Statistics

P/E Ratio 50.1
PEG Ratio -0.9
Market Cap Cr 3,008
Price to Book Ratio 5.6
EPS 10.4
Dividend 3.2
Relative Strength Index 55.48
Money Flow Index 61.99
MACD Signal 2.53
Average True Range 17.15

Thyrocare Technologies Investment Rating

  • Master Rating:
  • Thyrocare Technologies has an operating revenue of Rs. 533.77 Cr. on a trailing 12-month basis. An annual revenue de-growth of -13% needs improvement, Pre-tax margin of 17% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 9% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 32 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Thyrocare Technologies Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 124125117125119123
Operating Expenses Qtr Cr 9010291968587
Operating Profit Qtr Cr 332326303437
Depreciation Qtr Cr 999889
Interest Qtr Cr 111111
Tax Qtr Cr 855869
Net Profit Qtr Cr 171013142020
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 492569
Operating Expenses Annual Cr 374331
Operating Profit Annual in Cr 112231
Depreciation Cr 3428
Interest Annual Cr 22
Tax Annual Cr 2455
Net Profit Annual Cr 57152
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 120106
Cash from Investing Activity Annual Cr -32-12
Cash from Financing Annual Activity Cr -88-87
Net Cash Flow Annual Cr 16
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 521521
Fixed Assets Annual Cr 157152
Total Non Current Assets Annual Cr 377366
Total Current Assets Annual Cr 235231
Total Assets Annual Cr 612597
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 9898
ROE Annual % 1129
ROCE Annual % 1539
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2442
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 135136128135128131
Operating Expenses Qtr Cr 1011111001039293
Operating Profit Qtr Cr 342528323638
Depreciation Qtr Cr 1011109910
Interest Qtr Cr 111111
Tax Qtr Cr 855869
Net Profit Qtr Cr 171315152221
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 535618
Operating Expenses Annual Cr 407354
Operating Profit Annual in Cr 120235
Depreciation Cr 3934
Interest Annual Cr 22
Tax Annual Cr 2452
Net Profit Annual Cr 64176
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 129113
Cash from Investing Activity Annual Cr -39-24
Cash from Financing Annual Activity Cr -86-89
Net Cash Flow Annual Cr 40
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 534527
Fixed Assets Annual Cr 195188
Total Non Current Assets Annual Cr 360338
Total Current Assets Annual Cr 273270
Total Assets Annual Cr 633608
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 101100
ROE Annual % 1233
ROCE Annual % 1642
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2445

Thyrocare Technologies Technicals

EMA & SMA

Current Price
₹568.3
14.5 (2.62%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹558.32
  • 50 Day
  • ₹551.05
  • 100 Day
  • ₹538.74
  • 200 Day
  • ₹552.07
  • 20 Day
  • ₹557.89
  • 50 Day
  • ₹560.72
  • 100 Day
  • ₹526.93
  • 200 Day
  • ₹518.91

Thyrocare Technologies Resistance and Support

PIVOT
₹566.07
Resistance
First Resistance ₹577.19
Second Resistance ₹586.07
Third Resistance ₹597.19
RSI 55.48
MFI 61.99
MACD Single Line 2.53
MACD 2.41
Support
First Resistance ₹557.19
Second Resistance ₹546.07
Third Resistance ₹537.19

Thyrocare Technologies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 78,445 2,616,141 33.35
Week 35,339 1,504,381 42.57
1 Month 83,828 4,319,645 51.53
6 Month 184,346 9,152,766 49.65

Thyrocare Technologies Result Highlights

Thyrocare Technologies Synopsis

NSE-Medical-Services

Thyrocare Tech. is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 486.46 Cr. and Equity Capital is Rs. 52.93 Cr. for the Year ended 31/03/2023. Thyrocare Technologies Ltd. is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882.
Market Cap 3,008
Sales 491
Shares in Float 1.53
No of funds 47
Yield 3.17
Book Value 5.77
U/D Vol ratio 1.1
LTDebt / Equity
Alpha -0.09
Beta 0.52

Thyrocare Technologies

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 71.14%71.14%71.14%71.14%
Mutual Funds 12.04%7.03%7.3%6.81%
Insurance Companies 1.08%1.08%1.08%1.85%
Foreign Portfolio Investors 3.44%9.99%10.13%10.42%
Financial Institutions/ Banks
Individual Investors 9.42%8.38%8.07%7.28%
Others 2.88%2.38%2.28%2.5%

Thyrocare Technologies Management

Name Designation
Mr. Rahul Guha Managing Director & CEO
Mr. Dharmil Sheth Non Executive Director
Mr. Hardik Dedhia Non Executive Director
Mr. Dhaval Shah Non Executive Director
Mr. Gopalkrishna Shivram Hegde Independent Director
Dr. Indumati Gopinathan Independent Director
Dr. Neetin S Desai Independent Director

Thyrocare Technologies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Thyrocare Technologies Corporate Action

Date Purpose Remarks
2023-08-01 Quarterly Results
2023-05-23 Audited Results
2023-04-07 Interim Dividend
2023-02-03 Quarterly Results
2022-11-11 Quarterly Results
Date Purpose Remarks
2023-04-20 INTERIM Rs.18.00 per share(180%)Interim Dividend
2022-05-12 FINAL Rs.15.00 per share(150%)Interim Dividend

Thyrocare Technologies MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 36540
ICICI Prudential India Opportunities Fund Regular Growth 11294
Nippon India Pharma Fund - Growth 5545
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3174
Nippon India Retirement Fund - Wealth Creation Scheme - Regular Growth 2605
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Thyrocare Technologies FAQs

What is Share Price of Thyrocare Technologies ?

Thyrocare Technologies share price is ₹568 As on 30 September, 2023 | 18:37

What is the Market Cap of Thyrocare Technologies ?

The Market Cap of Thyrocare Technologies is ₹3008 Cr As on 30 September, 2023 | 18:37

What is the P/E ratio of Thyrocare Technologies ?

The P/E ratio of Thyrocare Technologies is 50.1 As on 30 September, 2023 | 18:37

What is the PB ratio of Thyrocare Technologies ?

The PB ratio of Thyrocare Technologies is 5.6 As on 30 September, 2023 | 18:37

Q2FY23